XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2
Segments (Tables)
6 Months Ended
Jun. 30, 2022
Segments  
Revenue and Pre-tax Income by Segment

Total

 

(Dollars in millions)

Software

Consulting

Infrastructure

Financing

Segments

 

For the three months ended June 30, 2022:

 

  

 

  

 

  

 

  

 

  

Revenue

$

6,166

$

4,809

$

4,235

$

146

$

15,355

Pre-tax income from continuing operations

$

1,375

$

343

$

757

$

102

$

2,577

Revenue year-to-year change

 

6.4

%  

 

9.8

%  

 

19.0

%  

 

(29.9)

%  

 

10.1

%

Pre-tax income year-to-year change

 

29.9

%  

 

26.9

%  

 

54.8

%  

 

(22.4)

%  

 

32.2

%

Pre-tax income margin

 

22.3

%  

 

7.1

%  

 

17.9

%  

 

69.7

%  

 

16.8

%

For the three months ended June 30, 2021*:

 

  

 

  

 

  

 

  

 

  

Revenue

$

5,795

$

4,378

$

3,560

$

209

$

13,941

Pre-tax income from continuing operations

$

1,059

$

270

$

489

$

131

$

1,949

Pre-tax income margin

 

18.3

%  

 

6.2

%  

 

13.7

%  

 

63.0

%

 

14.0

%

Total

 

(Dollars in millions)

Software

Consulting

Infrastructure

Financing

Segments

 

For the six months ended June 30, 2022:

 

  

 

  

 

  

 

  

 

  

Revenue

$

11,938

$

9,637

$

7,453

$

300

$

29,328

Pre-tax income from continuing operations

$

2,509

$

691

$

956

$

186

$

4,342

Revenue year-to-year change

 

9.2

%  

 

11.5

%  

 

8.8

%  

 

(28.0)

%  

 

9.3

%

Pre-tax income year-to-year change

 

46.2

%  

 

26.3

%  

 

22.5

%  

 

(18.9)

%  

 

32.6

%

Pre-tax income margin

 

21.0

%  

 

7.2

%  

 

12.8

%  

 

62.0

%  

 

14.8

%

For the six months ended June 30, 2021*:

 

  

 

  

 

  

 

  

 

  

Revenue

$

10,933

$

8,641

$

6,853

$

417

$

26,843

Pre-tax income from continuing operations

$

1,717

$

547

$

780

$

229

$

3,274

Pre-tax income margin

 

15.7

%

 

6.3

%

 

11.4

%

 

55.0

%

 

12.2

%

Reconciliation of segment revenue and pre-tax income to IBM as reported

Reconciliations to IBM as Reported:

(Dollars in millions)

    

    

    

    

 

For the three months ended June 30:

2022

2021*

 

Revenue:

 

  

 

  

Total reportable segments

$

15,355

$

13,941

Otherdivested businesses

 

162

 

197

Other revenue

 

18

 

80

Total consolidated revenue

$

15,535

$

14,218

Pre-tax income from continuing operations:

 

  

 

  

Total reportable segments

$

2,577

$

1,949

Amortization of acquired intangible assets

 

(458)

 

(456)

Acquisition-related (charges)/income

 

(2)

 

(18)

Non-operating retirement-related (costs)/income

 

(192)

 

(317)

Kyndryl-related impacts**

(145)

 

Eliminations of internal transactions

 

(4)

 

5

Otherdivested businesses

 

160

+

 

(50)

Unallocated corporate amounts and other

 

(215)

 

(202)

Total pre-tax income from continuing operations

$

1,722

$

912

*

Recast to conform to current year presentation.

** Refer to note 8, “Financial Assets & Liabilities,” for additional information.

+ Includes a gain from the sale of the company’s healthcare software assets. Refer to note 6, “Acquisitions & Divestitures.”

Reconciliations to IBM as Reported:

(Dollars in millions)

    

    

    

    

 

For the six months ended June 30:

2022

2021*

 

Revenue:

 

  

 

  

Total reportable segments

$

29,328

$

26,843

Otherdivested businesses

 

316

 

394

Other revenue

 

88

 

167

Total consolidated revenue

$

29,732

$

27,405

Pre-tax income from continuing operations:

 

  

 

  

Total reportable segments

$

4,342

$

3,274

Amortization of acquired intangible assets

 

(919)

 

(903)

Acquisition-related charges

 

(9)

 

(34)

Non-operating retirement-related (costs)/income

 

(394)

 

(649)

Kyndryl-related impacts**

(367)

Eliminations of internal transactions

 

(15)

 

(4)

Otherdivested businesses

 

109

+

 

(65)

Unallocated corporate amounts

 

(403)

 

(464)

Total pre-tax income from continuing operations

$

2,345

$

1,155

*

Recast to conform to current year presentation.

**

Refer to note 8, “Financial Assets & Liabilities,” for additional information.

+ Includes a gain from the sale of the company’s healthcare software assets. Refer to note 6, “Acquisitions & Divestitures.”